These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 18552242
1. Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan. Yamamoto H, Kasai K, Hamada C, Hasegawa H, Higuchi C, Hiramatsu M, Hosoya T, Itami N, Kawanishi H, Kubota M, Masakane I, Minakuchi J, Mitarai T, Nakao T, Suzuki H, Tomo T, Kawaguchi Y, Japan Peritoneal Dialysis-Mineral Bone Disorders (PD-MBD) Research Group. Perit Dial Int; 2008 Jun; 28 Suppl 3():S128-30. PubMed ID: 18552242 [Abstract] [Full Text] [Related]
2. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Weinreich T, Ritz E, Passlick-Deetjen J. Perit Dial Int; 1996 Jun; 16(3):260-8. PubMed ID: 8761540 [Abstract] [Full Text] [Related]
3. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis. Brandi L, Nielsen PK, Bro S, Daugaard H, Olgaard K. J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798 [Abstract] [Full Text] [Related]
4. Calcium concentration in the CAPD dialysate: what is optimal and is there a need to individualize? Bro S, Brandi L, Daugaard H, Olgaard K. Perit Dial Int; 1997 Aug; 17(6):554-9. PubMed ID: 9655154 [Abstract] [Full Text] [Related]
5. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group. Weinreich T, Passlick-Deetjen J, Ritz E. Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324 [Abstract] [Full Text] [Related]
6. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study. Honkanen E, Kala AR, Grönhagen-Riska C, Ikäheimo R. Adv Perit Dial; 1992 Mar; 8():356-61. PubMed ID: 1361822 [Abstract] [Full Text] [Related]
7. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Cho MS, Lee KS, Lee YK, Ma SK, Ko JH, Kim SW, Kim NH, Choi KC. Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088 [Abstract] [Full Text] [Related]
8. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone. Bro S, Brandi L, Olgaard K. Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216 [Abstract] [Full Text] [Related]
9. [The impact of low calcium dialysate (1.25 mmol/l; LCD) on bone metabolism in CAPD patients]. Terawaki H, Kasai K, Kawaguchi Y, Kobayashi H, Hirano K, Ohtsuka Y, Hosoya T. Nihon Jinzo Gakkai Shi; 1998 May; 40(4):252-7. PubMed ID: 9654908 [Abstract] [Full Text] [Related]
10. Hypercalcemia during pulse vitamin D3 therapy in CAPD patients treated with low calcium dialysate: the role of the decreasing serum parathyroid hormone level. Chagnac A, Ori Y, Weinstein T, Zevin D, Korzets A, Hirsh J, Edelstein S, Gafter U. J Am Soc Nephrol; 1997 Oct; 8(10):1579-86. PubMed ID: 9335387 [Abstract] [Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
17. Low-calcium dialysate as a risk factor for decline in bone mineral density in peritoneal dialysis patients. Kang SH, Cho KH, Park JW, Yoon KW, Do JY. Scand J Urol Nephrol; 2012 Dec; 46(6):454-60. PubMed ID: 22938029 [Abstract] [Full Text] [Related]
18. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder. Cheng IK, Lu HB, Chan CY, Cheng SW, Robinson JD, Tam SC, Lo WK, Cheung WC. Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365 [Abstract] [Full Text] [Related]
19. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients. Dong J, Wang H, Wang M. J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311 [Abstract] [Full Text] [Related]
20. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover. Shigematsu T, Kawaguchi Y, Kubo H, Nakayama M, Kato N, Yamamoto H, Osaka N, Hayakawa H, Ogawa A, Sakai O. Adv Perit Dial; 1996 Nov; 12():250-6. PubMed ID: 8865914 [Abstract] [Full Text] [Related] Page: [Next] [New Search]